Utilization of Mental Health Prescription Claims in Texas Health Plan Members in Relationship to the Novel Coronavirus Pandemic

Objective: To evaluate the utilization of mental health disorder prescription claims in relationship to the novel coronavirus pandemic. Methods Design: Retrospective analysis of mental health utilization prescription claims between March 2020 to August 2020 compared to March 2019 to August 2019. Inclusion, ≥ 18 years of age, Prescription claims for anti-anxiety, anti-depressant, anti-psychotic/anti-maniac agents, Health Plan members filling prescriptions within the state of Texas. Exclusions, < 18 years old. Data Collection, Mail and Retail Pharmacy utilization claims data: March 2020 – August 2020 & March 2019 – August 2019, Gender, Fill date, Member age. Statistical Analysis, Chi-Square Test to identify a P-value for the primary endpoint Endpoints " Primary o Difference between the number of mental health utilization prescription claims between March 2020 to August 2020 compared to March 2019 to August 2019 " Secondary o Difference in utilization rate between men and women o Difference in age o Percentage of patients receiving Mail vs Retail claims (pre/post COVID) o Comparing public health infection rate data vs. prescription claim rate (pre/post COVID) Results: For all primary endpoints, statistical significance was observed with p-values < 0.001. Conclusion: Work-In-Progress, N/A ©2020 CVS Health and/or one of its affiliates. All rights reserved. This article contains proprietary information and cannot be reproduced, distributed or printed without written permission from CVS Health. Data use and disclosure is subject to applicable law, corporate information firewalls and client contractual limitations.